FDA
label_change
· 2018-07-11
FDA Approved: DEXTROSE AND ELECTROLYTE NO. 48 — Supplemental Application (Baxter Healthcare Company)
Summary
FDA approved a supplemental application for Dextrose and Electrolyte No. 48, updating the product’s labeling for an IV solution containing sodium lactate, potas…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for DEXTROSE AND ELECTROLYTE NO. 48 (SODIUM LACTATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, MONOBASIC POTASSIUM PHOSPHATE, SODIUM CHLORIDE AND DEXTROSE MONOHYDRATE)